Algorithmiq
Quantum drug discovery at light speed
Helsinki, Finland
Algorithmiq is a quantum computing company that develops advanced algorithms to solve complex problems in drug discovery and molecular structure prediction, aiming to make the process faster and more cost-effective.
How We Help
Problem Statement
Drug discovery and design are computationally complex, making them slow, inefficient, and costly with classical computers. Algorithmiq addresses this by using advanced quantum algorithms to accelerate and improve the accuracy of molecular simulations.
Core Technology
Quantum Computing
Key Differentiators
Development of noise-resilient quantum algorithms; Seamless integration of classical and quantum computing; Quantum Network Medicine approach combining AI with quantum computing; Informationally Complete framework for error mitigation
Clinical Focus
Drug Discovery; Molecular Simulation; Drug Metabolism; Photodynamic Cancer Therapy; Epilepsy Research; Cell Biology
Company Info
- Business Model
- Hybrid
- Total Funding
- 19,000,000
- Website
- algorithmiq.fi
Categories
Technologies
Clinical & IP
Clinical Validation
Finalist in Wellcome Leap Quantum for Bio Challenge; $4.25M award for photon-activated cancer drug research with Cleveland Clinic and IBM; validated error mitigation at IBM Quantum Summit 2023
MedStartr Index Score
?What do you think of Algorithmiq?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.